CN111096367A - 一种具有增加骨密度、增强人体免疫力的功能性组合配方奶粉及其生产工艺 - Google Patents
一种具有增加骨密度、增强人体免疫力的功能性组合配方奶粉及其生产工艺 Download PDFInfo
- Publication number
- CN111096367A CN111096367A CN201811265567.6A CN201811265567A CN111096367A CN 111096367 A CN111096367 A CN 111096367A CN 201811265567 A CN201811265567 A CN 201811265567A CN 111096367 A CN111096367 A CN 111096367A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- milk powder
- zinc
- enhancer
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 74
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 29
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 25
- 239000011707 mineral Substances 0.000 title claims abstract description 25
- 241000282414 Homo sapiens Species 0.000 title claims abstract description 21
- 230000036039 immunity Effects 0.000 title claims abstract description 17
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 12
- 230000001965 increasing effect Effects 0.000 title claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 title abstract description 8
- 210000000988 bone and bone Anatomy 0.000 title description 4
- 229940088594 vitamin Drugs 0.000 claims abstract description 27
- 229930003231 vitamin Natural products 0.000 claims abstract description 27
- 235000013343 vitamin Nutrition 0.000 claims abstract description 27
- 239000011782 vitamin Substances 0.000 claims abstract description 27
- 239000003623 enhancer Substances 0.000 claims abstract description 26
- 235000010755 mineral Nutrition 0.000 claims abstract description 24
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000011701 zinc Substances 0.000 claims abstract description 20
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 20
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000011669 selenium Substances 0.000 claims abstract description 18
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 18
- 239000002131 composite material Substances 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 16
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 14
- 235000015097 nutrients Nutrition 0.000 claims abstract description 13
- 230000037182 bone density Effects 0.000 claims abstract description 8
- -1 compound vitamin Chemical class 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims abstract description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 7
- 229930006000 Sucrose Natural products 0.000 claims abstract description 7
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 7
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 7
- 235000021119 whey protein Nutrition 0.000 claims abstract description 7
- 235000011649 selenium Nutrition 0.000 claims description 16
- 229940091258 selenium supplement Drugs 0.000 claims description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 8
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 6
- 229960001231 choline Drugs 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 4
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 claims description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 4
- 239000004277 Ferrous carbonate Substances 0.000 claims description 4
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims description 4
- 102000010445 Lactoferrin Human genes 0.000 claims description 4
- 108010063045 Lactoferrin Proteins 0.000 claims description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- 108010001441 Phosphopeptides Proteins 0.000 claims description 4
- 229920001100 Polydextrose Polymers 0.000 claims description 4
- 102000008114 Selenoproteins Human genes 0.000 claims description 4
- 108010074686 Selenoproteins Proteins 0.000 claims description 4
- 229930003316 Vitamin D Natural products 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 claims description 4
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 4
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 4
- 239000004227 calcium gluconate Substances 0.000 claims description 4
- 235000013927 calcium gluconate Nutrition 0.000 claims description 4
- 229960004494 calcium gluconate Drugs 0.000 claims description 4
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 4
- 239000001527 calcium lactate Substances 0.000 claims description 4
- 235000011086 calcium lactate Nutrition 0.000 claims description 4
- 229960002401 calcium lactate Drugs 0.000 claims description 4
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 4
- 239000005018 casein Substances 0.000 claims description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 4
- 235000021240 caseins Nutrition 0.000 claims description 4
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 4
- RAQDACVRFCEPDA-UHFFFAOYSA-L ferrous carbonate Chemical compound [Fe+2].[O-]C([O-])=O RAQDACVRFCEPDA-UHFFFAOYSA-L 0.000 claims description 4
- 235000019268 ferrous carbonate Nutrition 0.000 claims description 4
- 229960004652 ferrous carbonate Drugs 0.000 claims description 4
- 239000004225 ferrous lactate Substances 0.000 claims description 4
- 235000013925 ferrous lactate Nutrition 0.000 claims description 4
- 229940037907 ferrous lactate Drugs 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 4
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 4
- 229910000015 iron(II) carbonate Inorganic materials 0.000 claims description 4
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 4
- 235000021242 lactoferrin Nutrition 0.000 claims description 4
- 229940078795 lactoferrin Drugs 0.000 claims description 4
- 239000001755 magnesium gluconate Substances 0.000 claims description 4
- 235000015778 magnesium gluconate Nutrition 0.000 claims description 4
- 229960003035 magnesium gluconate Drugs 0.000 claims description 4
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims description 4
- 239000011656 manganese carbonate Substances 0.000 claims description 4
- 235000006748 manganese carbonate Nutrition 0.000 claims description 4
- 229940093474 manganese carbonate Drugs 0.000 claims description 4
- 229910000016 manganese(II) carbonate Inorganic materials 0.000 claims description 4
- XMWCXZJXESXBBY-UHFFFAOYSA-L manganese(ii) carbonate Chemical compound [Mn+2].[O-]C([O-])=O XMWCXZJXESXBBY-UHFFFAOYSA-L 0.000 claims description 4
- 235000001968 nicotinic acid Nutrition 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- 239000011664 nicotinic acid Substances 0.000 claims description 4
- 229940055726 pantothenic acid Drugs 0.000 claims description 4
- 235000019161 pantothenic acid Nutrition 0.000 claims description 4
- 239000011713 pantothenic acid Substances 0.000 claims description 4
- 235000013856 polydextrose Nutrition 0.000 claims description 4
- 239000001259 polydextrose Substances 0.000 claims description 4
- 229940035035 polydextrose Drugs 0.000 claims description 4
- 239000001508 potassium citrate Substances 0.000 claims description 4
- 229960002635 potassium citrate Drugs 0.000 claims description 4
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 4
- 235000011082 potassium citrates Nutrition 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 239000011655 sodium selenate Substances 0.000 claims description 4
- 235000018716 sodium selenate Nutrition 0.000 claims description 4
- 229960001881 sodium selenate Drugs 0.000 claims description 4
- 239000011781 sodium selenite Substances 0.000 claims description 4
- 235000015921 sodium selenite Nutrition 0.000 claims description 4
- 229960001471 sodium selenite Drugs 0.000 claims description 4
- 229960003080 taurine Drugs 0.000 claims description 4
- 235000019166 vitamin D Nutrition 0.000 claims description 4
- 239000011710 vitamin D Substances 0.000 claims description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 4
- 229940046008 vitamin d Drugs 0.000 claims description 4
- 239000011667 zinc carbonate Substances 0.000 claims description 4
- 235000004416 zinc carbonate Nutrition 0.000 claims description 4
- 229910000010 zinc carbonate Inorganic materials 0.000 claims description 4
- 239000011670 zinc gluconate Substances 0.000 claims description 4
- 235000011478 zinc gluconate Nutrition 0.000 claims description 4
- 229960000306 zinc gluconate Drugs 0.000 claims description 4
- 239000011576 zinc lactate Substances 0.000 claims description 4
- 235000000193 zinc lactate Nutrition 0.000 claims description 4
- 229940050168 zinc lactate Drugs 0.000 claims description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 2
- 229930003451 Vitamin B1 Natural products 0.000 claims description 2
- 229930003779 Vitamin B12 Natural products 0.000 claims description 2
- 229930003471 Vitamin B2 Natural products 0.000 claims description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 229960003495 thiamine Drugs 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- 235000010374 vitamin B1 Nutrition 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 235000019163 vitamin B12 Nutrition 0.000 claims description 2
- 239000011715 vitamin B12 Substances 0.000 claims description 2
- 235000019164 vitamin B2 Nutrition 0.000 claims description 2
- 239000011716 vitamin B2 Substances 0.000 claims description 2
- 235000019158 vitamin B6 Nutrition 0.000 claims description 2
- 239000011726 vitamin B6 Substances 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- 229940043825 zinc carbonate Drugs 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- 235000020604 functional milk Nutrition 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 235000013336 milk Nutrition 0.000 abstract description 5
- 239000008267 milk Substances 0.000 abstract description 5
- 210000004080 milk Anatomy 0.000 abstract description 5
- 238000004806 packaging method and process Methods 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 description 23
- 239000000047 product Substances 0.000 description 14
- 239000000463 material Substances 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 229960005069 calcium Drugs 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000011261 inert gas Substances 0.000 description 4
- 238000007873 sieving Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010058314 Dysplasia Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000012744 reinforcing agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010013883 Dwarfism Diseases 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229960002358 iodine Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000008621 organismal health Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000007084 physiological dysfunction Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000005313 thymus development Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明的目的在于提供一种能增加骨密度、增强人体免疫力的功能性组合配方奶粉及其生产工艺。该奶粉每1000g配方由以下组分组成:脱脂奶粉:800‑850g,乳清蛋白粉:50~100g,白糖粉:50~100g,复合矿物质:2~10g,复合维生素:12~25g,复合锌强化剂:2~10g,复合硒强化剂:2~10g,其它配方奶粉允许添加的营养素20~50g。所述复合矿物质、复合维生素、复合锌强化剂、复合硒强化剂、其它配方奶粉允许添加的营养素均按照科学实验严格配比形成。该奶粉生产工艺,包括以下步骤:一级预混,二级预混,三级混合,包装。该产品对增强人体免疫力,预防疾病,有明显效果。
Description
技术领域
本发明涉及一种配方奶粉及其生产工艺,尤其是涉及一种能增加骨密度、增强人体免疫力的功能性组合配方奶粉及其生产工艺。
背景技术
免疫力是指机体抵抗外来侵袭,维护体内环境稳定性的能力。人之所以能健康、平安的生活,全都依赖于免疫***的正常运行。它可以与人体外的病毒进行斗争,防止细菌侵入人体,防范疾病的发生。宝宝出生后,从母体获得的抗体在六个月左右逐步减少、消失,而此时,宝宝自身的免疫能力还尚未健全。同时,六个月前的宝宝接触病原体的机会比较少,六个月后,这种机会逐步增加,这些都是六个月后的宝宝容易生病的直接原因。减少宝宝生病的机会,除了按时预防接种,坚持母乳喂养,多做户外活动外,还可以通过有意食用具有增强免疫力的配方奶粉来提高人体的抵抗力,减少疾病的发生。
维生素是维持身体健康所必需的一类有机化合物。这类物质在体内既不是构成身体组织的原料,也不是能量的来源,而是一类调节物质,在物质代谢中起重要作用。这类物质由于体内不能合成或合成量不足,所以虽然需要量很少,但必须经常由食物供给。维生素对机体的新陈代谢、生长、发育、健康有极重要作用,如果长期缺乏某种维生素,就会引起生理机能障碍而发生某种疾病。
矿物质,又称无机盐,是构成人体组织和维持正常生理功能必需的各种元素的总称,矿物质对骨骼生长具有极其重要作用,对增加骨密度具有积极作用。矿物质和维生素一样,是人体必需的元素,矿物质是无法自身产生、合成的,每天矿物质的摄取量也是基本确定的,对于生长发育期的少年儿童,对于矿物质的需求量很大,因此,通过食物补充矿物质成为一种趋势。人体如果长期缺乏某种矿物质就会带来疾病,影响骨骼健康,甚至导致身体病变,造成终生残疾。
硒能够调节维生素A、维生素C、维生素E、维生素K的吸收与利用,当硒缺乏的时候,就很容易导致人体免疫能力下降,威胁人类健康,尤其是青少年儿童,缺硒对生长发育带来极为不利影响。
锌可以增强人体免疫力,人体体内锌含量如果长期处于缺乏状态,就会引起疾病,尤其对于生长发育期的青少年,如果缺锌就会导致发育不良,缺乏严重时,将会导致″侏儒症″和智力发育不良。只有锌量充足才能有效保证胸腺发育,正常分化淋巴细胞,促进细胞免疫功能。
大量研究表明,我国国民身体普遍表现为缺乏钙、铁、锌、硒、碘等微量元素。在食品中有意补充添加维生素、矿物质、硒元素、锌元素等营养强化剂,就可以增加骨密度、抑制钙流失、增强人体免疫力,减少疾病的发生。
发明内容
本发明的目的在于提供一种能增加骨密度、增强人体免疫力的功能性配方奶粉及其生产工艺。
本发明的目的是通过以下技术方案实现的:
一种增加骨密度、增强人体免疫力的功能性组合配方奶粉,其特征在于每1000g配方奶粉由以下组分组成:
脱脂奶粉:800-850g,乳清蛋白粉:50~100g,白糖粉:50~100g,复合矿物质:2~10g,复合维生素:12~25g,复合锌强化剂:2~10g,复合硒强化剂:2~10g,其它配方婴幼儿配方奶粉允许添加的营养素20~50g。
上述复合矿物质由碳酸亚铁、乳酸亚铁、葡萄糖酸钙、乳酸钙、葡萄糖酸镁、柠檬酸钾、碳酸锰中的一种或多种组成。
上述复合维生素由维生素B1、维生素B2、维生素B6、维生素C、维生素B12、维生素D、叶酸、烟酸、泛酸、胆碱中的一种或多种组成。
上述复合锌强化剂由乳酸锌、碳酸锌、葡萄糖酸锌中的一种或多种组成。
上述复合硒强化剂由硒蛋白、硒酸钠、***钠中的一种或多种组成。
上述其他配方奶粉允许添加的营养素由左旋肉碱、牛磺酸、低聚果糖、酪蛋白磷酸肽、聚葡萄糖、乳铁蛋白中的一种或多种组成。
上述复合矿物质各组分重量比例如下(总数是1):碳酸亚铁0--0.3,乳酸亚铁0--0.3,葡萄糖酸钙0.1--0.4,乳酸钙0.1--0.4,葡萄糖酸镁0--0.2,柠檬酸钾0--0.2,碳酸锰0--0.2。
上述复合维生素各组分重量比例如下(总数是1):维生素B1 0--0.15,维生素B20--0.15,维生素B6 0--0.15,维生素C 0.1--0.3,维生素B12 0--0.3,维生素D 0--0.15,叶酸0--0.1,烟酸0--0.1,泛酸0--0.1,胆碱0--0.1。
上述复合锌强化剂各组分重量比例如下(总数是1):乳酸锌0.2--0.8,碳酸锌0--0.5,葡萄糖酸锌0--0.4。
上述复合硒强化剂各组分重量比例如下(总数是1):硒蛋白0--0.5,硒酸钠0--0.5,***钠0--0.5。
上述其他配方奶粉允许添加的营养素各组分重量比例如下(总数是1):左旋肉碱0--0.2,牛磺酸0--0.2,低聚果糖0.1--0.4,酪蛋白磷酸肽0--0.2,聚葡萄糖0.2--0.5,乳铁蛋白0--0.3。
本发明之一种增加骨密度、增强人体免疫力的功能性配方奶粉的生产工艺,包括以下步骤:
(1)依次将1-3倍于复合矿物质、复合维生素、复合锌增强剂、复合硒增强剂、其它配方奶粉允许添加的营养素总重量的脱脂奶粉和复合矿物质原料、复合维生素原料、复合锌增强剂原料、复合硒增强剂原料、其它配方奶粉允许添加的营养素原料倒入三维混合机中进行一级预混,预混时间为5--8min。
(2)将一级预混后的物料按照总重量的1--2倍再配入脱脂奶粉,将脱脂奶粉倒入三维混合机中,加入乳清蛋白粉、白糖粉进行二级预混,预混时间为5--8min。
(3)将二级预混后的物料投入高速混合机中,加入配方中剩余的脱脂奶粉,进行三级混合,转速35-45转/min,混合时间为5--8min。
(4)混合后的产品过40目筛后转入移动粉车,放入粉斗,抽真空填充惰性气体进行包装,即成。
本发明通过将复合矿物质、复合维生素、复合锌增强剂、复合硒增强剂添加到奶粉中,使奶粉的营养成分更全面,弥补国人身体普遍缺乏的营养元素。该产品各成分协同作用,对促进钙吸收、抑制钙流失,增加骨密度、增强身体免疫力,预防疾病,效果显著,对人体健康起到积极作用。
具体实施方式
下面结合实施例对本发明作进一步说明。
以下所述各实施例配方为生产100公斤产品所需。
实施例1
制备工艺:
(1)把10公斤脱脂奶粉投入三维混合机,然后依次将称量好的矿物质组分原料、维生素组分原料、锌增强剂组分原料、硒增强剂组分原料、其它配方奶粉允许添加的营养素组分原料倒入三维混合机中,进行一级预混,预混时间为6min。
(2)将一级预混后的物料再配入20公斤脱脂奶粉、5公斤乳清蛋白粉、5公斤白糖粉于三维混合机中,进行二级预混,预混时间为6min。
(3)将二级预混后的物料投入到高速混合机中,同时加入脱脂奶粉50公斤,进行三级混合,转速35-45转/min,混合时间为5min。
混合后的产品过40目筛后转入移动粉车,放入粉斗,抽真空填充惰性气体进行包装,即成。
实施例2
制备工艺:
(1)把15公斤脱脂奶粉投入三维混合机,然后依次将称量好的矿物质组分原料、维生素组分原料、锌增强剂组分原料、硒增强剂组分原料、其它配方奶粉允许添加的营养素组分原料倒入三维混合机中,进行一级预混,预混时间为6min。
(2)将一级预混后的物料再配入20公斤脱脂奶粉、6公斤乳清蛋白粉、7公斤白糖粉于三维混合机中,进行二级预混,预混时间为6min。
(3)将二级预混后的物料投入到高速混合机中,同时加入脱脂奶粉47公斤,进行三级混合,转速35-45转/min,混合时间为5min。
混合后的产品过40目筛后转入移动粉车,放入粉斗,抽真空填充惰性气体进行包装,即成。
实施例3
制备工艺:
(1)把15公斤脱脂奶粉投入三维混合机,然后依次将称量好的矿物质组分原料、维生素组分原料、锌增强剂组分原料、硒增强剂组分原料、其它配方奶粉允许添加的营养素组分原料倒入三维混合机中,进行一级预混,预混时间为6min。
(2)将一级预混后的物料再配入20公斤脱脂奶粉、5公斤乳清蛋白粉、5公斤白糖粉于三维混合机中,进行二级预混,预混时间为6min。
(3)将二级预混后的物料投入到高速混合机中,同时加入脱脂奶粉50公斤,进行三级混合,转速35-45转/min,混合时间为5min。
混合后的产品过40目筛后转入移动粉车,放入粉斗,抽真空填充惰性气体进行包装,即成。
Claims (3)
1.一种具有增加骨密度、增强人体免疫力的功能性组合配方奶粉,其特征在于每1000g配方奶粉由以下组分组成:脱脂奶粉:800-850g,乳清蛋白粉:50~100g,白糖粉:50~100g,复合矿物质:2~10g,复合维生素:12~25g,复合锌强化剂:2~10g,复合硒强化剂:2~10g,其它配方奶粉允许添加的营养素20~50g。
2.如权利要求1所述的一种具有增加骨密度、增强人体免疫力的功能性组合配方奶粉,其特征是所述复合矿物质由碳酸亚铁、乳酸亚铁、葡萄糖酸钙、乳酸钙、葡萄糖酸镁、柠檬酸钾、碳酸锰中的一种或多种组成;所述复合维生素由维生素B1、维生素B2、维生素B6、维生素C、维生素B12、维生素D、叶酸、烟酸、泛酸、胆碱中的一种或多种组成;所述复合锌强化剂由乳酸锌、碳酸锌、葡萄糖酸锌中的一种或多种组成;所述复合硒强化剂由硒蛋白、硒酸钠、***钠中的一种或多种组成;所述其它配方奶粉允许添加的营养素由左旋肉碱、牛磺酸、低聚果糖、酪蛋白磷酸肽、聚葡萄糖、乳铁蛋白中的一种或多种组成。
3.如权利要求1或权利要求2所述的一种具有增加骨密度、增强人体免疫力的功能性组合配方奶粉,其特征在于所述复合矿物质各组分重量比例如下(总数是1):碳酸亚铁0--0.3,乳酸亚铁0--0.3,葡萄糖酸钙0.1--0.4,乳酸钙0.1--0.4,葡萄糖酸镁0--0.2,柠檬酸钾0--0.2,碳酸锰0--0.2;所述复合维生素各组分重量比例如下(总数是1):维生素B1 0--0.15,维生素B2 0--0.15,维生素B6 0--0.15,维生素C 0.1--0.3,维生素B12 0--0.3,维生素D 0--0.15,叶酸0--0.1,烟酸0--0.1,泛酸0--0.1,胆碱0--0.1;所述复合锌强化剂各组分重量比例如下(总数是1):乳酸锌0.2--0.8,碳酸锌0--0.5,葡萄糖酸锌0--0.4;所述复合硒强化剂各组分重量比例如下(总数是1):硒蛋白0--0.5,硒酸钠0--0.5,***钠0--0.5;所述其它配方奶粉允许添加的营养素各组分重量比例如下(总数是1):左旋肉碱0--0.2,牛磺酸0--0.2,低聚果糖0.1--0.4,酪蛋白磷酸肽0--0.2,聚葡萄糖0.2--0.5,乳铁蛋白0--0.3。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811265567.6A CN111096367A (zh) | 2018-10-29 | 2018-10-29 | 一种具有增加骨密度、增强人体免疫力的功能性组合配方奶粉及其生产工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811265567.6A CN111096367A (zh) | 2018-10-29 | 2018-10-29 | 一种具有增加骨密度、增强人体免疫力的功能性组合配方奶粉及其生产工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111096367A true CN111096367A (zh) | 2020-05-05 |
Family
ID=70420324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811265567.6A Pending CN111096367A (zh) | 2018-10-29 | 2018-10-29 | 一种具有增加骨密度、增强人体免疫力的功能性组合配方奶粉及其生产工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111096367A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111990464A (zh) * | 2020-08-27 | 2020-11-27 | 海普诺凯营养品有限公司 | 一种提升配方奶粉成分均匀性的混料方法 |
CN115024361A (zh) * | 2021-03-03 | 2022-09-09 | 内蒙古伊利实业集团股份有限公司 | 一种改善骨健康的配方牛奶及制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104982533A (zh) * | 2015-07-17 | 2015-10-21 | 多加多乳业(天津)有限公司 | 一种增强婴幼儿免疫力的配方奶粉及制备方法 |
CN106615138A (zh) * | 2016-12-23 | 2017-05-10 | 杭州千岛湖康诺邦健康产品有限公司 | 一种母乳营养补充剂及其制备方法 |
-
2018
- 2018-10-29 CN CN201811265567.6A patent/CN111096367A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104982533A (zh) * | 2015-07-17 | 2015-10-21 | 多加多乳业(天津)有限公司 | 一种增强婴幼儿免疫力的配方奶粉及制备方法 |
CN106615138A (zh) * | 2016-12-23 | 2017-05-10 | 杭州千岛湖康诺邦健康产品有限公司 | 一种母乳营养补充剂及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111990464A (zh) * | 2020-08-27 | 2020-11-27 | 海普诺凯营养品有限公司 | 一种提升配方奶粉成分均匀性的混料方法 |
CN115024361A (zh) * | 2021-03-03 | 2022-09-09 | 内蒙古伊利实业集团股份有限公司 | 一种改善骨健康的配方牛奶及制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102696760B (zh) | 一种婴幼儿配方奶粉及其制备方法 | |
Trailokya et al. | Calcium and calcium salts | |
CN108029768A (zh) | 一种含乳铁蛋白和益生菌的婴幼儿配方奶粉及其制备方法 | |
CN102038041B (zh) | 一种婴幼儿矿物质配方奶粉 | |
US11224246B2 (en) | Mineral fortification process and its uses | |
KR101432088B1 (ko) | 미네랄 성분 및/또는 비타민 성분을 포함하는 희석액 및 고체 식품 | |
CN107173816A (zh) | 一种增强免疫力助消化婴幼儿营养包制剂 | |
CN110881526A (zh) | 一种促进铁吸收的组合物及其应用 | |
CN111096367A (zh) | 一种具有增加骨密度、增强人体免疫力的功能性组合配方奶粉及其生产工艺 | |
CN103125602A (zh) | 一种加力功能化婴幼儿配方奶粉 | |
CN103169092A (zh) | 一种l-天门冬氨酸螯和钙水 | |
CN107927198A (zh) | 一种用于早产儿饮用奶粉及其制备方法 | |
Davison | Mineral nutrients: from macro-level to ultra trace | |
US20170245533A1 (en) | Fortified Micronutrient Product and Methods of Use and Manufacture | |
JP2016019536A (ja) | 疲労回復(recharge)用の電解質強化組成物、栄養補助水、及びその調製方法 | |
US10080379B2 (en) | Zinc and copper fortifying composition, a hydrating supplement, and process for preparing the same | |
US20220249546A1 (en) | Beverage fortified with ferrous bisglycinate | |
AU2015218429B2 (en) | Micronutrient Fortification Process and its Uses | |
CN105521480A (zh) | 一种适用于10岁以下儿童的复合维生素片 | |
Haghighatdoost et al. | Trace Minerals | |
Nielsen | 13 Trace Mineral Deficiencies | |
CN113995127A (zh) | 一种全营养配方食品及其制备方法 | |
Nielsen | Trace Mineral Defi ciencies | |
Bae et al. | A Case of Hypocalcemia due to Vitamin D Deficiency in Exclusively Breast-fed Infant. | |
NZ603441B (en) | Micronutrient Fortification Process and its Uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200505 |
|
WD01 | Invention patent application deemed withdrawn after publication |